A phase 2 clinical trial found that ataciguat, a soluble guanylate cyclase activator, may slow aortic valve calcification and help preserve cardiac function in patients with moderate calcific aortic valve...
A phase 2 clinical trial found that ataciguat, a soluble guanylate cyclase activator, may slow aortic valve calcification and help preserve cardiac function in patients with moderate calcific aortic valve...
A Stanford-led session offered clinicians a practical roadmap for integrating AI into primary care, highlighting foundational concepts, real-world applications, and a framework for evaluating AI tools based...
A Stanford-led session offered clinicians a practical roadmap for integrating AI into primary care, highlighting foundational concepts, real-world applications, and a framework for evaluating AI tools based...
A Stanford-led session offered clinicians a practical roadmap for integrating AI into primary care, highlighting foundational concepts, real-world applications, and a framework for evaluating AI tools based...
A Stanford-led session offered clinicians a practical roadmap for integrating AI into primary care, highlighting foundational concepts, real-world applications, and a framework for evaluating AI tools based...
As the clinical use of GLP-1 receptor agonists (RA) expands beyond diabetes and obesity, clinicians must balance emerging cardiometabolic and organ-specific benefits with the challenges of persistent...
As the clinical use of GLP-1 receptor agonists (RA) expands beyond diabetes and obesity, clinicians must balance emerging cardiometabolic and organ-specific benefits with the challenges of persistent...
As the clinical use of GLP-1 receptor agonists (RA) expands beyond diabetes and obesity, clinicians must balance emerging cardiometabolic and organ-specific benefits with the challenges of persistent...
As the clinical use of GLP-1 receptor agonists (RA) expands beyond diabetes and obesity, clinicians must balance emerging cardiometabolic and organ-specific benefits with the challenges of persistent...
